VERTEPORFIN

Search structure
Trade Names:
Synonyms:
Status: Approved (2000)
Entry Type: Small molecule
Molecule Category: UNKNOWN
ATC: S01LA01
UNII: 0X9PA28K43

Structure
InChI Key NJLRKAMQPVVOIU-IXZGEAKMSA-N
Smile C=Cc1c(C)c2cc3nc(cc4[nH]c(cc5nc(cc1[nH]2)C(C)=C5CCC(=O)O)c(CCC(=O)OC)c4C)C1(C)C3=CC=C(C(=O)OC)C1C(=O)OC.C=Cc1c(C)c2cc3nc(cc4[nH]c(cc5nc(cc1[nH]2)C(C)=C5CCC(=O)OC)c(CCC(=O)O)c4C)C1(C)C3=CC=C(C(=O)OC)C1C(=O)OC
InChI
InChI=1S/2C41H42N4O8/c1-9-23-20(2)29-17-34-27-13-10-26(39(49)52-7)38(40(50)53-8)41(27,5)35(45-34)19-30-22(4)24(11-14-36(46)47)32(44-30)18-33-25(12-15-37(48)51-6)21(3)28(43-33)16-31(23)42-29;1-9-23-20(2)29-17-34-27-13-10-26(39(49)52-7)38(40(50)53-8)41(27,5)35(45-34)19-30-22(4)25(12-15-37(48)51-6)33(44-30)18-32-24(11-14-36(46)47)21(3)28(43-32)16-31(23)42-29/h2*9-10,13,16-19,38,42,44H,1,11-12,14-15H2,2-8H3,(H,46,47)/b2*28-16-,29-17-,30-19-,31-16-,32-18-,33-18-,34-17-,35-19-

Physicochemical Descriptors

Property Name Value
Molecular Formula C82H84N8O16
Molecular Weight 1437.61
AlogP None
Hydrogen Bond Acceptor None
Hydrogen Bond Donor None
Number of Rotational Bond None
Polar Surface Area None
Molecular species None
Aromatic Rings None
Heavy Atoms None

Pharmacology

Action Mechanism of Action Reference
INHIBITOR DNA inhibitor
Targets EC50(nM) IC50(nM) Kd(nM) Ki(nM) Inhibition(%)
Enzyme Hydrolase
- - - -
Enzyme Transferase
- - - - 7.783
Epigenetic regulator Eraser Histone deacetylase HDAC class IIb
- - - - 11.53-22.2
Transcription factor
- 1122 - - -
Unclassified protein
- 1122 - - -

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Macular Degeneration 4 D008268 ClinicalTrials
Myopia, Degenerative 4 D047728 ClinicalTrials
Choroidal Neovascularization 3 D020256 ClinicalTrials
Carcinoma, Basal Cell 3 D002280 ClinicalTrials
Basal Cell Nevus Syndrome 3 D001478 ClinicalTrials
Pancreatic Neoplasms 2 D010190 ClinicalTrials
Breast Neoplasms 2 D001943 ClinicalTrials
Histoplasmosis 2 D006660 ClinicalTrials
Pancreatic Neoplasms 2 D010190 ClinicalTrials
Glioblastoma 1 D005909 ClinicalTrials
Pleural Effusion 1 D010996 ClinicalTrials
Melanoma 1 D008545 ClinicalTrials
Central Nervous System Neoplasms 1 D016543 ClinicalTrials
Neoplasms 1 D009369 ClinicalTrials
Prostatic Neoplasms, Castration-Resistant 1 D064129 ClinicalTrials

Related Entries

Scaffolds

Adverse Reactions

SOC By Demographic Distribution
System Organ Classification (SOC)
Relative Frequency (%)
Eye disorders
36.61
Vascular disorders
17.07
Injury, poisoning and procedural complications
13.58
General disorders and administration site conditions
11.64
Nervous system disorders
7.61
Skin and subcutaneous tissue disorders
2.27

Cross References

Resources Reference
CAS NUMBER 129497-78-5
ChEMBL CHEMBL2218885
FDA SRS 0X9PA28K43
CONTENTS